IHM
CADX

Iguana Healthcare Management’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Iguana Healthcare Management’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-50,000
Closed -$453K – 107
2013
Q4 		$453K Buy
+50,000
New +$361K 0.26% 67

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Iguana Healthcare Management's CADX Position: Q1 2014 in Review

Iguana Healthcare Management sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 50,000 shares — an estimated $453K sold.

Iguana Healthcare Management first reported a position in CADX in Q4 2013 and held it in 1 quarter. The position peaked at $453K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Iguana Healthcare Management reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Iguana Healthcare Management sold 50,000 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $453K.
  • Iguana Healthcare Management first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q4 2013 and held it in 1 quarter.
  • Iguana Healthcare Management's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $453K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Iguana Healthcare Management's 13F filing for Q1 2014, filed 16 May 2014.